Optimizing surgical care: A contemporary assessment of temperature, oxygen, and glucose

American Surgeon

Volumn 76, Issue 6, 2010, Pages 571-577

  Dickinson, Ashley ^a   Qadan, Motaz ^a   Polk Jr , Hiram C ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HLA DR ANTIGEN; INSULIN; OXYGEN; TUMOR NECROSIS FACTOR ALPHA;

BLOOD VESSEL PERMEABILITY; CLINICAL ASSESSMENT; CRITICALLY ILL PATIENT; CYTOKINE RELEASE; EVIDENCE BASED PRACTICE; FEVER; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE QUALITY; HUMAN; HYPERGLYCEMIA; HYPERTHERMIA; HYPOGLYCEMIA; HYPOTHALAMUS; HYPOTHERMIA; INFLAMMATION; INNATE IMMUNITY; INSULIN TREATMENT; LYMPHOCYTE ACTIVATION; MACROPHAGE; MORTALITY; NEUTROPHIL; NOTE; OXYGEN THERAPY; POSTOPERATIVE CARE; RISK BENEFIT ANALYSIS; SEPSIS; SURGICAL INFECTION; TEMPERATURE;

BLOOD GLUCOSE; BODY TEMPERATURE; CRITICAL ILLNESS; FEVER; HUMANS; HYPOTHERMIA; IMMUNITY, INNATE; INTRAOPERATIVE PERIOD; MONOCYTES; POSTOPERATIVE CARE; SEPSIS; SURGICAL WOUND INFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953592142     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (62)

1. Miles AA, Miles EM, Burke J. The value and duration of defence reactions of the skin to the primary lodgement of bacteria. Br J Exp Pathol 1957;38:79-96.
2. Hopf HW, Hunt TK, West JM, et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg 1997;132:997-1004.
3. Kluger MJ. Fever - its biology, evolution and function. Princeton, NJ: Princeton University Press; 1979.
4. Hasday JD, Garrison A. Antipyretic therapy in patients with sepsis. Clin Infect Dis 2000;31(suppl 5):S234-41.
5. Ostberg JR, Repasky EA. Comparison of the effects of two different whole body hyperthermia protocols on the distribution of murine leukocyte populations. Int J Hyperthermia 2000;16: 29-43.
6. Kimura A, Sakurada S, Ohkuni H, et al. Moderate hypothermia delays proinflammatory cytokine production of human peripheral blood mononuclear cells. Crit Care Med 2002;30:1499-502.
7. Ensor JE, Wiener SM, McCrea KA, et al. Differential effects of hyperthermia on macrophage interleukin-6 and tumor necrosis factor-alpha expression. Am J Physiol 1994;266:C967-74.
8. Jiang Q, Cross AS, Singh IS, et al. Febrile core temperature is essential for optimal host defense in bacterial peritonitis. Infect Immun 2000;68:1265-70.
9. Fairchild KD, Viscardi RM, Hester L, et al. Effects of hypothermia and hyperthermia on cytokine production by cultured human mononuclear phagocytes from adults and newborns. J Interferon Cytokine Res 2000;20:1049-55.
10. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996;334:1209-15.
11. Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA 1997;277:1127-34.
12. Luna GK, Maier RV, Pavlin EG, et al. Incidence and effect of hypothermia in seriously injured patients. J Trauma 1987;27: 1014-8.
13. Schmied H, Kurz A, Sessler DI, et al. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996;347:289-92.
14. Lenhardt R, Negishi C, Sessler DI. Perioperative fever. Acta Anaesthesiol Scand Suppl 1997;111:325-8.
15. Carli F, Emery PW, Freemantle CA. Effect of perioperative normothermia on postoperative protein metabolism in elderly patients undergoing hip arthroplasty. Br J Anaesth 1989;63:276-82.
16. Kurz A, Plattner O, Sessler DI, et al. The threshold for thermoregulatory vasoconstriction during nitrous oxide/isoflurane anesthesia is lower in elderly than in young patients. Anesthesiology 1993;79:465-9.
17. Peng RY, Bongard FS. Hypothermia in trauma patients. J Am Coll Surg 1999;188:685-96.
18. Kluger MJ, KozakW, Conn CA, et al. The adaptive value of fever. Infect Dis Clin North Am 1996;10:1-20.
19. Kurz A. Physiology of thermoregulation. Best Pract Res Clin Anaesthesiol 2008;22:627-44.
20. Galandiuk S, Mahid SS, Polk HC Jr, et al. Differences and similarities between rural and urban operations. Surgery 2006;140: 589-96.
21. Allen DB, Maguire JJ, Mahdavian M, et al. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg 1997;132:991-6.
22. Greif R, Akca O, Horn EP, et al. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N Engl J Med 2000;342:161-7.
23. Leijh PC, van den Barselaar MT, van Zwet TL, Dubbeldeman-Rempt I. van FR. Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. Immunology 1979;37: 453-65.
24. van Oss CJ, Absolom DR, Moore LL, et al. Effect of temperature on the chemotaxis, phagocytic engulfment, digestion and O2 consumption of human polymorphonuclear leukocytes. J Reticuloendothel Soc 1980;27:561-5.
25. Wenisch C, Narzt E, Sessler DI, et al. Mild intraoperative hypothermia reduces production of reactive oxygen intermediates by polymorphonuclear leukocytes. Anesth Analg 1996;82:810-6.
26. Ditschkowski M, Kreuzfelder E, Rebmann V, et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg 1999;229:246-54.
27. Livingston DH, Appel SH, Wellhausen SR, et al. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 1988;123:1309-12.
28. Polk HC Jr, Trachtenberg L, George CD. A randomized, double-blind trial of single dose piperacillin versus multidose cefoxitin in alimentary tract operations. Am J Surg 1986;152: 517-21.
29. Cheadle WG, Wilson M, Hershman MJ, et al. Comparison of trauma assessment scores and their use in prediction of infection and death. Ann Surg 1989;209:541-5.
30. HershmanMJ, CheadleWG,Wellhausen SR, et al.Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990;77:204-7.
31. Qadan M, Gardner SA, Vitale DS, et al. Hypothermia and surgery: Immunologic mechanisms for current practice. Ann Surg 2009 Jul;250(1):134-40.
32. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229:869-71.
33. Van der Poll T, Keogh CV, BuurmanWA, Lowry SF. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med 1997;155:603-8.
34. Van der Poll T. Immunotherapy of sepsis. Lancet Infect Dis 2001;1:165-74.
35. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987;330:662-4.
36. Lekkou A, Karakantza M, Mouzaki A, et al. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004;11:161-7.
37. Qadan M, Akca O, Mahid SS, et al. Perioperative supplemental oxygen therapy and surgical site infection: a meta-analysis of randomized controlled trials. Arch Surg 2009;144:359-66.
38. Myles PS, Leslie K, Chan MT, et al. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology 2007;107:221-31.
39. Fleischmann E, Lenhardt R, Kurz A, et al. Nitrous oxide and risk of surgical wound infection: a randomised trial. Lancet 2005; 366:1101-7.
40. Pryor KO, Fahey TJ III, Lien CA, Goldstein PA. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA 2004;291:79-87.
41. Dellinger EP. Increasing inspired oxygen to decrease surgical site infection: time to shift the quality improvement research paradigm. JAMA 2005;294:2091-2.
42. Jonsson K, Jensen JA, GoodsonWHIII, et al. Assessment of perfusion in postoperative patients using tissue oxygen measurements. Br J Surg 1987;74:263-7.
43. Hartmann M, Jonsson K, Zederfeldt B. Effect of tissue perfusion and oxygenation on accumulation of collagen in healing wounds. Randomized study in patients after major abdominal operations. Eur J Surg 1992;158:521-6.
44. Bassler D, Ferreira-Gonzalez I, Briel M, et al. Systematic reviewers neglect bias that results from trials stopped early for benefit. J Clin Epidemiol 2007;60:869-73.
45. Belda FJ, Aguilera L, Garcia dlA, et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 2005;294:2035-42.
46. Gendall KA, Raniga S, Kennedy R, Frizelle FA. The impact of obesity on outcome after major colorectal surgery. Dis Colon Rectum 2007;50:2223-37.
47. Kabon B, Nagele A, Reddy D, et al. Obesity decreases perioperative tissue oxygenation. Anesthesiology 2004;100:274-80.
48. Gardella C, Goltra LB, Laschansky E, et al. High-concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstet Gynecol 2008;112:545-52.
49. Maragakis LL, Cosgrove SE, Martinez EA, et al. Intraoperative fraction of inspired oxygen is a modifiable risk factor for surgical site infection after spinal surgery. Anesthesiology 2009; 110:556-62.
50. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345: 1359-67.
51. Bochicchio GV, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005;58:921-4.
52. Laird AM, Miller PR, Kilgo PD, et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004;56: 1058-62.
53. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acutemyocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
54. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003;55:33-8.
55. Doenst T, Wijeysundera D, Karkouti K, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005;130:1144.
56. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003;75:1392-9.
57. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005;80:862-6.
58. Latham R, Lancaster AD, Covington JF, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001;22:607-12.
59. Turina M, Miller FN, Tucker CF, Polk HC. Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms. Ann Surg 2006;243:845-51.
60. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008;300:933-44.
61. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-97.
62. Qadan M, Battista C, Gardner SA, et al. Oxygen and surgical site infection: A study of underlying immunologic mechanisms. Anesthesiology. In press.